Erratum: Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: Follow-up from PREVENT IV randomized clinical trail (JAMA Surgery (2014) DOI:10.1001/jamasurg.2014.87);Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: Follow-up from PREVENT IV randomized clinical trail

JAMA Surgery

Volumn 149, Issue 8, 2014, Pages 798-805

  Harskamp, Ralf E ^a,b   Alexander, John H ^a   Schulte, Phillip J ^a   Brophy, Colleen M ^c   Mack, Michael J ^d   Peterson, Eric D ^a   Williams, Judson B ^a   Gibson, C Michael ^e   Califf, Robert M ^f   Kouchoukos, Nicholas T ^g   Harrington, Robert A ^h   Ferguson Jr , T Bruce ⁱ   Lopes, Renato D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VANDERBILT UNIVERSITY   (United States)

^d Cardiopulmonary Research Science and Technology Institute   (United States)

^e PERFUSE Angiographic Laboratory   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MISSOURI BAPTIST MEDICAL CENTER   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFERED SALINE; PLACEBO; PRESERVATION SOLUTION; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

BLOOD; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FOLLOW UP; GRAFT FAILURE; GRAFT PRESERVATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; VEIN GRAFT;

AGED; BUFFERS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDES; ORGAN PRESERVATION SOLUTIONS; SODIUM CHLORIDE; TREATMENT OUTCOME; VASCULAR PATENCY; VEINS;

EID: 84906658329     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.87     Document Type: Erratum

References (32)

1. Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE; RAPS Investigators. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012;60(1):28-35.
2. Harskamp RE, Lopes RD, Baisden CE, deWinter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013;257(5):824-833.
3. Tsakok M, Montgomery-Taylor S, Tsakok T. Storage of saphenous vein grafts prior to coronary artery bypass grafting: is autologous whole blood more effective than saline in preserving graft function? Interact Cardiovasc Thorac Surg. 2012;15 (4):720-725.
4. Alexander JH, Hafley G, Harrington RA, et al; PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294(19): 2446-2454.
5. Alexander JH, Ferguson TB Jr, Joseph DM, et al; PREVENT IV Investigators. The Project of Ex-vivo Vein Graft Engineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. Am Heart J. 2005; 150(4):643-649.
6. Lopes RD, Mehta RH, Hafley GE, et al; Project of Ex Vivo Vein Graft Engineering via Transfection IV (PREVENT IV) Investigators. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. 2012;125(6):749-756.
7. Lopes RD, Williams JB, Mehta RH, et al. Edifoligide and long-term outcomes after coronary artery bypass grafting: Project of Ex-vivo Vein Graft Engineering via Transfection IV (PREVENT IV) 5-year results. Am Heart J. 2012;164(3):379-386.e1. doi: 10.1016/j.ahj.2012.05.019.
8. Lamm P, Juchem G, Milz S, Reichart B. Continuous graft perfusion: optimizing the quality of saphenous vein grafts. Heart Surg Forum. 2002;5 (suppl 4):S355-S361.
9. WilbringM, Tugtekin SM, Zatschler B, et al. Even short-time storage in physiological saline solution impairs endothelial vascular function of saphenous vein grafts. Eur J Cardiothorac Surg. 2011;40(4):811-815.
10. Souza DS, Dashwood MR, Tsui JC, et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann Thorac Surg. 2002;73(4):1189-1195.
11. Catinella FP, Cunningham JN Jr, Srungaram RK, et al. The factors influencing early patency of coronary artery bypass vein grafts: correlation of angiographic and ultrastructural findings. J Thorac Cardiovasc Surg. 1982;83(5):686-700.
12. Gundry SR, JonesM, Ishihara T, Ferrans VJ. Optimal preparation techniques for human saphenous vein grafts. Surgery. 1980;88(6):785-794.
13. Bush HL Jr, Jakubowski JA, Curl GR, Deykin D, Nabseth DC. The natural history of endothelial structure and function in arterialized vein grafts. J Vasc Surg. 1986;3(2):204-215.
14. Lawrie GM,Weilbacher DE, Henry PD. Endothelium-dependent relaxation in human saphenous vein grafts: effects of preparation and clinicopathologic correlations. J Thorac Cardiovasc Surg. 1990;100(4):612-620.
15. Chester AH, O'Neil GS, Tadjakarimi S, Borland JA, Yacoub MH. Effect of peri-operative storage solution on the vascular reactivity of the human saphenous vein. Eur J Cardiothorac Surg. 1993;7(8): 399-404.
16. Santoli E, Di Mattia D, Boldorini R,Mingoli A, Tosoni A, Santoli C. University ofWisconsin solution and human saphenous vein graft preservation: preliminary anatomic report. Eur J Cardiothorac Surg. 1993;7(10):548-552.
17. Weiss DR, Juchem G, Kemkes BM, Gansera B, Nees S. Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. Int J Clin Exp Med. 2009;2(2):95-113.
18. Dumanski A, Sopel M, Pelczar M, Szłapka M, KustrzyckiW, Zabel M. Influence of pressure on the endothelium of the saphenous vein coronary artery bypass graft. In Vivo. 2007;21(5):785-789.
19. Cavallari N, AbebeW, Mingoli A, et al. Functional and morphological evaluation of canine veins following preservation in different storage media. J Surg Res. 1997;68(2):106-115.
20. Sanchez AM,Wooldridge TA, Boerboom LE, Olinger GN, Almassi GH, Rusch NJ. Comparison of saphenous vein graft relaxation between Plasma-Lyte solution and normal saline solution. J Thorac Cardiovasc Surg. 1994;107(6):1445-1453.
21. Hickethier T, Dämmrich J, Silber RE, Finster S, Elert O. Ultrastructural investigations for reducing endothelial cell damage of vein grafts during CABG-operation and practical consequences. J Cardiovasc Surg (Torino). 1999;40(1):71-76.
22. Thatte HS, Biswas KS, Najjar SF, et al. Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg. 2003;75(4):1145-1152.
23. WilbringM, Tugtekin SM, Zatschler B, et al. Preservation of endothelial vascular function of saphenous vein grafts after long-time storage with a recently developed potassium-chloride and N-acetylhistidine enriched storage solution. Thorac Cardiovasc Surg. 2013;61(8):656-662.
24. Owens CD,Wake N, ConteMS, Gerhard-Herman M, Beckman JA. In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. J Vasc Surg. 2009;50(5):1063-1070.
25. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis. 1991;34(1):45-68.
26. Ehsan A, Mann MJ, Dell'Acqua G, Tamura K, Braun-Dullaeus R, Dzau VJ. Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation. 2002;105(14):1686-1692.
27. Tsui JC, Souza DS, Filbey D, Karlsson MG, Dashwood MR. Localization of nitric oxide synthase in saphenous vein grafts harvested with a novel "no-touch" technique: potential role of nitric oxide contribution to improved early graft patency rates. J Vasc Surg. 2002;35(2):356-362.
28. Dashwood MR, Savage K, Dooley A, Shi-Wen X, Abraham DJ, Souza DS. Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production. Ann Thorac Surg. 2005; 80(3):939-944.
29. Chung AW, Rauniyar P, Luo H, Hsiang YN, van Breemen C, Okon EB. Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and nitric oxide production. J Thorac Cardiovasc Surg. 2006;132(4):925-932.
30. Hinokiyama K, Valen G, Tokuno S, Vedin JB, Vaage J. Vein graft harvesting induces inflammation and impairs vessel reactivity. Ann Thorac Surg. 2006;82(4):1458-1464.
31. Davies MG, KlyachkinML, Dalen H, MasseyMF, Svendsen E, Hagen PO. The integrity of experimental vein graft endothelium: implications on the etiology of early graft failure. Eur J Vasc Surg. 1993;7(2):156-165.
32. Sasaki Y, Suehiro S, Becker AE, Kinoshita H, Ueda M. Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications. Heart. 2000;83(1):69-75.